Grupo de fisiopatología y terapéutica neurológica del Instituto del Niño y del Adolescente (INA) del Hospital Clínico San Carlos
NEURO-INA-IN
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2019
-
Cohort study showed that growth rate increment has not been enough to prevent growth retardation of preterm infants and raised concerns about unbalanced growth
Acta Paediatrica, International Journal of Paediatrics, Vol. 108, Núm. 10, pp. 1793-1800
-
Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia
PLoS ONE, Vol. 14, Núm. 3
-
Increased expression of cannabinoid CB2 and serotonin 5-HT1A heteroreceptor complexes in a model of newborn hypoxic-ischemic brain damage
Neuropharmacology, Vol. 152, pp. 58-66